PGC-1α gene and physical activity in type 2 diabetes mellitus

被引:11
|
作者
Franks, Paul W. [1 ]
Loos, Ruth J. F.
机构
[1] Umea Univ Hosp, Genet Epidemiol & Clin Res Grp, Inst Publ Hlth & Clin Med, S-90185 Umea, Sweden
[2] MRC, Epidemiol Unit, Genet Grp, Cambridge, England
来源
EXERCISE AND SPORT SCIENCES REVIEWS | 2006年 / 34卷 / 04期
基金
英国医学研究理事会;
关键词
PGC-1; alpha; PPARGCIA; gene-lifestyle interaction type 2 diabetes;
D O I
10.1249/01.jes.0000240021.92254.23
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Exercise stimulates PGC-1 alpha gene expression and increases VO(2)max, the latter of which relates inversely with type 2 diabetes risk. Consistently, low levels of PGC-1 alpha mRNA and nucleotide sequence variation at PGC-1 alpha associate with lower level Of VO(2)max and increased diabetes risk. Thus PGC-1 alpha sequence variation may interact with physical activity to modify diabetes risk via changes in oxidative energy metabolism.
引用
收藏
页码:171 / 175
页数:5
相关论文
共 50 条
  • [1] PGC-1α, glucose metabolism and type 2 diabetes mellitus
    Wu, Haijiang
    Deng, Xinna
    Shi, Yonghong
    Su, Ye
    Wei, Jinying
    Duan, Huijun
    JOURNAL OF ENDOCRINOLOGY, 2016, 229 (03) : R99 - R115
  • [2] PGC-1α at the crossroads of type 2 diabetes
    Alan D Attie
    Christina M Kendziorski
    Nature Genetics, 2003, 34 : 244 - 245
  • [3] PGC-1α at the crossroads of type 2 diabetes
    Attie, AD
    Kendziorski, CM
    NATURE GENETICS, 2003, 34 (03) : 244 - 245
  • [4] Hengshun Aromatic Vinegar Improves Glycolipid Metabolism in Type 2 Diabetes Mellitus via Regulating PGC-1α/PGC-1β Pathway
    Li, Guoquan
    Tan, Xuemei
    Zhang, Bao
    Guan, Linshu
    Zhang, Yidan
    Yin, Lianhong
    Gao, Meng
    Zhu, Shenghu
    Xu, Lina
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [5] PGC-1 may be a nobel susceptibility gene for insulin resistance and type 2 diabetes
    Hara, K
    Tobe, K
    Okada, T
    Kadowaki, H
    Akanuma, Y
    Ito, C
    Kadowaki, T
    DIABETES, 2002, 51 : A39 - A39
  • [6] Complex haplotypes of the PGC-1α gene are associated with carbohydrate metabolism and type 2 diabetes
    Oberkofler, H
    Linnemayr, V
    Weitgasser, R
    Klein, K
    Xie, MQ
    Iglseder, B
    Krempler, F
    Paulweber, B
    Patsch, W
    DIABETES, 2004, 53 (05) : 1385 - 1393
  • [7] Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes
    Sharabi, Kfir
    Lin, Hua
    Tavares, Clint D. J.
    Dominy, John E.
    Camporez, Joao Paulo
    Perry, Rachel J.
    Schilling, Roger
    Rines, Amy K.
    Lee, Jaemin
    Hickey, Marc
    Bennion, Melissa
    Palmer, Michelle
    Nag, Partha P.
    Bittker, Joshua A.
    Perez, Jose
    Jedrychowski, Mark P.
    Ozcan, Umut
    Gygi, Steve P.
    Kamenecka, Theodore M.
    Shulman, Gerald I.
    Schreiber, Stuart L.
    Griffin, Patrick R.
    Puigserver, Pere
    CELL, 2017, 169 (01) : 148 - +
  • [8] PGC-1α activation: a therapeutic target for type 2 diabetes?
    Daixiu Yuan
    Dingfu Xiao
    Qian Gao
    Liming Zeng
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2019, 24 : 385 - 395
  • [9] PGC-1 activation: a therapeutic target for type 2 diabetes?
    Yuan, Daixiu
    Xiao, Dingfu
    Gao, Qian
    Zeng, Liming
    EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2019, 24 (03) : 385 - 395
  • [10] Association of the PGC-1α rs8192678 variant with microalbuminuria in subjects with type 2 diabetes mellitus
    Prior, Sarah L.
    Clark, Amy R.
    Jones, Danielle A.
    Bain, Steve C.
    Hurel, Steve J.
    Humphries, Steve E.
    Stephens, Jeffrey W.
    DISEASE MARKERS, 2012, 32 (06) : 363 - 369